Điều trị thiếu máu thiếu sắt bằng bổ sung sắt đường tĩnh mạch trên bệnh nhân thận nhân tạo chu kỳ

Evaluate the results of treatment of iron deficiency anemia with intravenous iron supplementation in hemodialysis patients. Subject and methods: Using a prospective descriptive research method to compare results before and after 1 and 3 months of intravenous iron supplementation in patients with indications for intravenous iron infusion (TSAT < 30% and ferritin < 500ng/ml). Result: Iron concentration, serum ferritin, TSAT all increased significantly after iron infusion 1 month and 3 months. Hemoglobin concentration at time T0 was 94.26 ± 13.25 g/l, increasing to 105.32 ± 15.76 g/l after only 1 month of iron infusion. Approximately 50% of patients have an increase in hemoglobin concentration rate of ≥ 10 g/l/month. The proportion of patients with hemoglobin concentration >= 110 g/l accounted for 42.1% after 1 month and remained at 34.2% after 3 months of intravenous iron infusion. Only 2 patients had headaches, 1 patient had transient nausea and no patient had serious side effects. Conclusion: Intravenous iron supplementation for hemodialysis patients with iron deficiency has significantly improved anemia. At the same time, it still ensures safety and has less side effects.